Milestone Pharmaceuticals Inc
NASDAQ:MIST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Milestone Pharmaceuticals Inc
NASDAQ:MIST
|
CA |
|
Indospring Tbk PT
IDX:INDS
|
ID |
|
I
|
Iniziative Bresciane Inbre SpA
MIL:IB
|
IT |
|
F
|
Freehold Royalties Ltd
F:1FH
|
CA |
|
Amada Co Ltd
TSE:6113
|
JP |
|
M
|
Mitchells & Butlers PLC
XBER:MABB
|
UK |
|
Mitsui Chemicals Inc
OTC:MITUF
|
JP |
|
O
|
Outcrop Silver & Gold Corp
F:MRG
|
CA |
|
M
|
Max Estates Ltd
NSE:MAXESTATES
|
IN |
|
B
|
Bukit Asam Tbk PT
XMUN:TBA
|
ID |
|
AJ Bell PLC
F:3FY
|
UK |
|
A
|
Aurora Cannabis Inc
NASDAQ:ACB
|
CA |
|
A
|
Allied Gold Corp
TSX:AAUC
|
CA |
|
Team17 Group PLC
F:2EC
|
UK |
|
A
|
Atlantic Sapphire ASA
XMUN:4AS
|
NO |
Bankruptcy Probability
Milestone Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Milestone Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Milestone Pharmaceuticals Inc
NASDAQ:MIST
|
122.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
639.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
321.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
197.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
143.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Milestone Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Milestone Pharmaceuticals Inc has total debt of 136.3m USD. This includes both short-term (0 USD) and long-term (136.3m USD) debt.
You can find a full breakdown on its Balance Sheet.
